Monthly Archives: November 2023

Dissolution Testing and Development

An Introduction to Dissolution Testing and Development

Dissolution testing is the monitoring of drug substances in a controlled environment from a solid dosage form (i.e., capsules, tablets) to a solution state. These “tests to characterize the dissolution behavior of the dosage form, …also take disintegration characteristics into consideration, are usually conducted using methods and apparatus that have been standardized virtually worldwide over the past decade or so, as part of the ongoing effort to harmonize pharmaceutical manufacturing and quality control on a global basis.”1  

Devising a Strategy
When devising a dissolution testing strategy, “a simple but broadly applicable analytical method is always desired.”2 Dissolution analysis is generally performed via UHPLC for faster sample analysis due to the number of samples required. Creating an analytical method should incorporate guidelines from The European Medicines Agency’s (EMA) International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), which are also interchangeable with the FDA. These are designed to “avoid redundant testing by (the) industry.”3  

It’s the Media… 
Dissolution testing is designed to mimic conditions found in the human stomach.  As these conditions vary widely from patient to patient, so too should the testing environment. The ranges for the media should allow for various pH levels. These sets should be notated and designed to simulate FaSSGF (fasted state simulated gastric fluid), FeSSIF (fed state simulated intestinal fluid), and FaSSIF (fasted state simulated intestinal fluid). Compendial media is generally HCl or sometimes acetate or phosphate pharmacopeial buffers. As mentioned, with this many simulated environments, along with multiple time sets/points, there will be many samples necessary, and analysis by UHPLC is optimal for timely turnarounds.  

We Can Assist with your Dissolution Testing and Development Needs 

AMPAC Analytical has years of experience and numerous experts in dissolution testing. We can support release testing, stability, method development, and assist with formulation development through dissolution analysis. We utilize paddle and basket apparatuses in the dissolution phase of testing. Additionally, our equipment offerings include Agilent Infinity II and Thermo Fisher Vanquish Horizon UHPLCs.  Please contact us with any specific questions or to receive a quote for your drug product dissolution testing and development needs.    

References  

  1. https://www.academia.edu/download/33056117/Pharmaceutical_Dissolution_Testing.pdf#page=15 
  2. Development and Validation of an HPLC Method for Dissolution and Stability Assay of Liquid-Filled Cyclosporine Capsule Drug Products – PMC (nih.gov) 
  3. Q4B Annex 7 (R2): Dissolution Test General Chapter | FDA 

Resources  

Some Background and Concerns About PFAS

PFAS

The Background and Concerns of PFAS

PFSA structure(Per- and) PolyFluoroAlkyl Substances (PFAS) are a class of ubiquitous chemicals that have been found in water, air, fish, and soil across the nation and worldwide. Known as “Forever Chemicals,” there are thousands of different PFAS, and they are present in consumer, commercial, and industrial products.1 Having one of the strongest bonds in organic chemistry, their structures proved to be resistant to heat, water, oil, and degradation.2 They are found in “food packaging and non-stick cookware, cosmetics, waterproof and stain-proof textiles and carpet, aqueous film forming foam (AFFF) to fight Class B fires, and as part of metal plating processes.”3 Teflon and Scotchgard were two of the pioneering products to utilize these fluoropolymers. The two most common PFAS are perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS).

Health Concerns of PFAS

Some of the most frequently cited health concerns associated with PFAS include adverse cardiovascular, immunity, developmental, and hepatic effects.3,4The most commonly heard refrain to minimize these concerns is that if they are so prevalent, why are there
not more health issues associated with them? In fact, “The Lancet Commission on Pollution and Health reported that pollution was responsible for 9 million premature deaths in 2015, making it the world’s largest environmental risk factor for disease and
premature death.” This was updated in 2019, and those numbers held steady, accounting for one in six deaths worldwide.5/i> While this number includes all types of pollution, the impacts are clear.

The Exposure Concerns of PFAS Are Regulatory and Legal

Due to their combination of persistence, pervasiveness, mobility, and the ability of some to bioaccumulate (or build up in animals and humans), they have been in the news recently too.6 Predictably, they are also now moving through the courts.7-9 Some of the most common areas of litigation are directed at PFAS found in drinking water and firefighting foam. The regulatory initiatives are also increasing. These address a range from water and soil to numerous manmade products including food packaging.10,11 The European Chemicals Agency (ECHA) and the NIH have a wealth of guidance and regulations that apply to PFAS.12,13

PFAS Detection

The EPA has useful direction for analytical methods development and sampling research that outlines the “laboratory validation process following a particular rulemaking or guidance effort and are available to support regulatory or guidance activities.”14 For
technique and equipment, PFAS are typically analyzed by mass spectrometry, coupled with gas chromatography or liquid chromatography (GCMS and LCMS), which enables detection in the low parts per billion.

AMPAC Analytical has years of experience and numerous experts in trace analysis by mass spectrometry who can assist with method development for high-volume analyses for both common and atypical sample matrices that will allow you to stay ahead of evolving regulatory concerns. Please contact us with specific questions or to receive a quote for PFAS quantitation.

References

  1. PFAS Explained | US EPA
  2. Understanding Organofluorine Chemistry. An Introduction to the C–F bond – Chemical Society Reviews (RSC Publishing)
  3. PFAS Health Effects Database: Protocol for a Systematic Evidence Map – ScienceDirect
  4. Toxicological Profile for Perfluoroalkyls (cdc.gov)
  5. Pollution and Health: a Progress Update – The Lancet Planetary Health
  6. ‘Forever Chemicals’ Are Everywhere. What Are They Doing to Us? – The New York Times (nytimes.com)
  7. PFAS Settlements: Future of PFAS Litigation Landscape to be Determined by Upcoming Decision | Reuters
  8. PFAS: The New Frontier of Product Liability – ProQuest
  9. DuPont, Corteva, and Chemours Announce Resolution of Legacy PFAS Claims | DuPont
  10. Trends in the Regulation of Per- and Polyfluoroalkyl Substances (PFAS): A Scoping Review
  11. PFAS in Food Packaging: State-by-State Regulations – September 2023 | Bryan Cave Leighton Paisner – JDSupra
  12. Per- and Polyfluoroalkyl Substances (PFAS) – ECHA (europa.eu)
  13. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up – NCBI Bookshelf (nih.gov)
  14. PFAS Analytical Methods Development and Sampling Research | US EPA

Resources